Study of quadruple combination for induction resistant myeloma reveals novel imm...
Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
12 Dec 2019
KRd vs KTd followed by carfilzomib maintenance in newly diagnosed MM
Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria
12 Dec 2019
Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma
Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
12 Dec 2019
Eligibility criteria in acute myeloid leukaemia clinical trials
Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
12 Dec 2019
Moxetumomab pasudotox-tdfk in heavily retreated r/r hairy cell leukaemia
Dr Robert Kreitman - National Cancer Institute, Bethesda, USA
12 Dec 2019
Azacitidine plus nivolumab in older adults with AML or MDS
Prof Annette Hay - Queen's University, Ontario, Canada
12 Dec 2019
Venetoclax chemo combo active and well-tolerated in children with r/r AML
Dr Seth Karol - St. Jude Children’s Research Hospital, Memphis, USA
12 Dec 2019
Precision medicine treatment in older AML: Results of Beat AML master trial
Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA
10 Dec 2019
Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-...
Dr Karl Kilgore - Avalere Health, Bowie, USA
10 Dec 2019
Depth of response to daratumumab, lenalidomide, bortezomib, and dexamethasone im...
Prof Peter Voorhees - Levine Cancer Institute, Charlotte, USA
10 Dec 2019
CARTITIUDE-1: BCMA-targeted CAR T-cell therapy shows high response rates in pati...
Prof Deepu Madduri - Mount Sinai, New York, USA
10 Dec 2019
Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse ...
Dr Patrick Brown - Johns Hopkins University, Baltimore, USA
10 Dec 2019
